安大略省生命科学战略第二阶段的启动,投资146亿澳元,重点是研发、企业家支持和创新。 Ontario launches Phase 2 of life sciences strategy, investing $146M with a focus on R&D, entrepreneur support, and innovation.

安大略启动了生命科学战略第二阶段,承诺1.46亿美元,另外4 000万美元来自安大略省风险基金。 Ontario has initiated Phase 2 of its life sciences strategy, committing $146 million, with an additional $40 million from the Venture Ontario Fund. 此后自2018年以来投资50亿美元,创造了5 000个就业机会。 This follows $5 billion invested since 2018, creating 5,000 jobs. 新阶段的重点是推进研发、支持企业家和促进创新。 The new phase focuses on advancing R&D, supporting entrepreneurs, and fostering innovation. 它包括《保健创新途径》,以帮助保健组织采用新技术,目的是加强安大略省在生物制造和生命科学中的地位。 It includes the Health Innovation Pathway to aid healthcare organizations in adopting new technologies, aiming to strengthen Ontario's position in biomanufacturing and life sciences.